70.64 USD
-0.35 (-0.49%)
ChartMill assigns a Buy % Consensus number of 86% to MIRM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 89.76. This target is 27.07% above the current price.
MIRM was analyzed by 17 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about MIRM.
In the previous month the buy percentage consensus was at a similar level.
MIRM was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-05 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-11-05 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-16 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-09-24 | TD Cowen | Initiate | Buy |
| 2025-09-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-08-11 | Stifel | Reiterate | Buy |
| 2025-08-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-08-07 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-08-07 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-08-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-05-13 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2025-05-09 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-27 | Baird | Maintains | Outperform -> Outperform |
| 2025-02-24 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-13 | Baird | Maintains | Outperform -> Outperform |
| 2024-11-13 | Citigroup | Maintains | Buy -> Buy |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-17 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2024-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-08-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-08 | Baird | Maintains | Outperform -> Outperform |
| 2024-07-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-20 | Stifel | Maintains | Buy -> Buy |
| 2024-06-18 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-06-18 | JP Morgan | Maintains | Overweight -> Overweight |
MIRUM PHARMACEUTICALS INC / MIRM FAQ
Can you provide the average price target for MIRUM PHARMACEUTICALS INC stock?
17 analysts have analysed MIRM and the average price target is 89.76 USD. This implies a price increase of 27.07% is expected in the next year compared to the current price of 70.64.
What is the consensus rating for MIRUM PHARMACEUTICALS INC (MIRM) stock?
The consensus rating for MIRUM PHARMACEUTICALS INC (MIRM) is 85.8824 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover MIRUM PHARMACEUTICALS INC (MIRM) stock?
The number of analysts covering MIRUM PHARMACEUTICALS INC (MIRM) is 17.